|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 45/06 | |
| A61K 31/365 | |||
| A61K 31/5377 | |||
| A61K 31/444 | |||
| A61K 31/423 | |||
| A61P 7/02 |
| (11) | Patento numeris | 3213749 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 15854130.0 |
| Europos patento paraiškos padavimo data | 2015-10-30 | |
| (97) | Europos patento paraiškos paskelbimo data | 2017-09-06 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2020-08-12 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/CN2015/093305 |
| Data | 2015-10-30 |
| (87) | Numeris | WO 2016/066128 |
| Data | 2016-05-06 |
| (30) | Numeris | Data | Šalis |
| 201410606703 | 2014-10-30 | CN |
| (72) |
SUN, Yi, CN
|
| (73) |
Chengdu Baiyu Pharmaceutical Co., Ltd.,
Liu Tai Avenue No. 433 Chengdu National Cross-Straits Science and Technology Industrial Development Park Wenjiang District, Chengdu, Sichuan 610041,
CN
|
| (54) | PHARMACEUTICAL COMPOSITION CONTAINING GINKGOLIDE B AND XA FACTOR INHIBITOR, PREPARATION METHOD THEREOF AND USE THEREOF |
| PHARMACEUTICAL COMPOSITION CONTAINING GINKGOLIDE B AND XA FACTOR INHIBITOR, PREPARATION METHOD THEREOF AND USE THEREOF |